Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-24 Purchase |
2021-05-26 11:53 am |
Esperion Therapeutics Inc. | ESPR | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
100,000 | $20.22 | $2,021,620 | 4,477,964 (Direct) |
View |
| 2021-05-19 Purchase |
2021-05-21 2:06 pm |
Esperion Therapeutics Inc. | ESPR | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $20.37 | $4,073,960 | 4,377,964 (Direct) |
View |
| 2021-05-05 Purchase |
2021-05-07 3:23 pm |
Esperion Therapeutics Inc. | ESPR | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
230,000 | $20.21 | $4,648,482 | 4,177,964 (Direct) |
View |
| 2020-11-03 Purchase |
2020-11-04 4:37 pm |
Esperion Therapeutics Inc. | ESPR | BIOTECH TARGET N V BB BIOTECH AG 10% Owner |
200,000 | $25.31 | $5,062,120 | 3,947,964 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
18,700 | $0 | 70,352 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
22,450 | $0 | 116,828 (Direct) |
View |
| 2021-06-28 Option Award |
2021-07-08 07:30 am |
N/A 2031-06-28 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
151,220 | $0 | 151,220 (Direct) |
View |
| 2021-06-28 Option Award |
2021-06-30 4:27 pm |
N/A 2031-06-28 |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
63,900 | $0 | 63,900 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:19 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Berkowitz Jeffrey Director |
12,376 | $0 | 23,449 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:19 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
12,376 | $0 | 25,254 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:18 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | MCGOVERN MARK E Director |
12,376 | $0 | 28,449 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:18 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Shepard Jay Director |
12,376 | $0 | 23,449 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:18 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director |
12,376 | $0 | 23,449 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:17 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director |
12,376 | $0 | 31,768 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:16 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | JANNEY DANIEL Director |
12,376 | $0 | 48,014 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 4:16 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director |
12,376 | $0 | 28,416 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 5:06 pm |
N/A 2031-05-17 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
140,000 | $0 | 170,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
175,000 | $0 | 175,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Bartram Richard Chief Financial Officer |
55,000 | $0 | 73,617 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Hall Ashley Chief Development Officer |
38,000 | $0 | 53,500 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:00 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. Chief Operating Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2020-12-30 Exercise |
2020-12-31 4:09 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
10,700 | $2.096 | 385,657 (Direct) |
View |
| 2020-12-30 Exercise |
2020-12-31 4:09 pm |
N/A 2023-01-16 |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
10,700 | $0 | 385,657 (Direct) |
View |